Clinical Trials List
Protocol NumberTYNADOTE-2-001
Active
2017-06-01 - 2026-12-31
Phase II
Recruiting1
-
Trial Applicant
SINEW PHARMA INC.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 吳明玲 Division of Occupational Medicine
- 徐德福 Division of Emergency Medicine
- Jou-Fang Deng Division of Occupational Medicine
- 朱豐沅 Division of Occupational Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
0 participants
